Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
GMP manufacturing of Vvax001, a therapeutic anti-HPV vaccine based on recombinant viral particles.
Eur J Pharm Sci. 2020 Feb 15;143:105096. doi: 10.1016/j.ejps.2019.105096. Epub 2019 Oct 25.
Eur J Pharm Sci. 2020.
PMID: 31669389
Free article.
First-in-Human Phase I Clinical Trial of an SFV-Based RNA Replicon Cancer Vaccine against HPV-Induced Cancers.
Komdeur FL, Singh A, van de Wall S, Meulenberg JJM, Boerma A, Hoogeboom BN, Paijens ST, Oyarce C, de Bruyn M, Schuuring E, Regts J, Marra R, Werner N, Sluis J, van der Zee AGJ, Wilschut JC, Allersma DP, van Zanten CJ, Kosterink JGW, Jorritsma-Smit A, Yigit R, Nijman HW, Daemen T.
Komdeur FL, et al. Among authors: van zanten cj.
Mol Ther. 2021 Feb 3;29(2):611-625. doi: 10.1016/j.ymthe.2020.11.002. Epub 2020 Nov 5.
Mol Ther. 2021.
PMID: 33160073
Free PMC article.
Clinical Trial.
Item in Clipboard
Natural killer cell responses in renal transplant patients with cytomegalovirus infection.
Venema H, van den Berg AP, van Zanten C, van Son WJ, van der Giessen M, The TH.
Venema H, et al.
J Med Virol. 1994 Feb;42(2):188-92. doi: 10.1002/jmv.1890420216.
J Med Virol. 1994.
PMID: 7512614
Item in Clipboard
Cite
Cite